Wilms' tumor gene 1 (WT1) expression in subtypes of acute lymphoblastic leukemia (ALL) of adults and impact on clinical outcome

Annals of Hematology

Volumn 88, Issue 12, 2009, Pages 1199-1205

  Busse, Antonia ^a   Gökbuget, Nicola ^b   Siehl, Jan Michael ^a   Hoelzer, Dieter ^b   Schwartz, Stefan ^a   Rietz, Anika ^a   Thiel, Eckhard ^a   Keilholz, Ulrich ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b GOETHE UNIVERSITY   (Germany)

Author keywords

Adult ALL; WT1

Indexed keywords

MESSENGER RNA; WT1 PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; B CELL LEUKEMIA; CANCER CLASSIFICATION; CANCER SURVIVAL; CLINICAL ASSESSMENT; CONTROLLED STUDY; CYTOGENETICS; DISEASE FREE SURVIVAL; DISEASE MARKER; FEMALE; GENE EXPRESSION PROFILING; GENETIC VARIABILITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; FEMALE; GENE EXPRESSION REGULATION, LEUKEMIC; GENES, WILMS TUMOR; HUMANS; IMMUNOPHENOTYPING; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; RNA, MESSENGER; TREATMENT OUTCOME; WT1 PROTEINS; YOUNG ADULT;

EID: 70350292724     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-009-0746-2     Document Type: Article

References (36)

1. Haber DA, Housman DE (1992) Role of the WT1 gene in Wilms' tumour. Cancer Surv 12:105-117
2. Hohenstein P, Hastie ND (2006) The many facets of the Wilms' tumour gene, WT1. Hum Mol Genet 15(Spec No 2):R196-R201
3. Haber DA, Sohn RL, Buckler AJ et al (1991) Alternative splicing and genomic structure of the Wilms tumor gene WT1. Proc Natl Acad Sci USA 88(21):9618-9622. doi: 10.1073/pnas.88.21.9618
4. Pritchard-Jones K (1999) The Wilms tumour gene, WT1, in normal and abnormal nephrogenesis. Pediatr Nephrol 13(7):620-625
5. Kreidberg JA (1996) Gene targeting in kidney development. Med Pediatr Oncol 27(5):445-452. doi: 10.1002/ (SICI)1096-911X(199611)27:5<445::AID-MPO10>3.0.CO;2-9
6. Maurer U, Brieger J, Weidmann E et al (1997) The Wilms' tumor gene is expressed in a subset of CD34+ progenitors and downregulated early in the course of differentiation in vitro. Exp Hematol 25(9):945-950
7. Sugiyama H (2001) Wilms' tumor gene WT1: Its oncogenic function and clinical application. Int J Hematol 73(2):177-187. doi: 10.1007/ BF02981935
8. Algar EM, Khromykh T, Smith SI et al (1996) A WT1 antisense oligonucleotide inhibits proliferation and induces apoptosis in myeloid leukaemia cell lines. Oncogene 12(5):1005-1014
9. Inoue K, Tamaki H, Ogawa H et al (1998) Wilms' tumor gene (WT1) competes with differentiation-inducing signal in hematopoietic progenitor cells. Blood 91(8):2969-2976
10. Yamagami T, Sugiyama H, Inoue K et al (1996) Growth inhibition of human leukemic cells by WT1 (Wilms tumor gene) antisense oligodeoxynucleotides: Implications for the involvement of WT1 in leukemogenesis. Blood 87(7):2878-2884
11. Xue S, Gao L, Gillmore R et al (2004) WT1-targeted immunotherapy of leukaemia. Blood Cells Mol Dis 33(3):288-290. doi: 10.1016/ j.bcmd.2004.08.018
12. Keilholz U, Menssen HD, Gaiger A et al (2005) Wilms' tumour gene 1 (WT1) in human neoplasia. Leukemia 19(8):1318-1323. doi: 10.1038/sj.leu.2403817
13. Oka Y, Tsuboi A, Oji Y et al (2008) WT1 peptide vaccine for the treatment of cancer. Curr Opin Immunol 20(2):211-220. doi: 10.1016/ j.coi.2008.04.009
14. Cilloni D, Messa F, Carturan S et al (2004) Myelodysplastic syndromes. Ann N Y Acad Sci 1028:400-408. doi: 10.1196/annals.1322.048
15. Menssen HD, Renkl HJ, Rodeck U et al (1995) Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias. Leukemia 9(6):1060-1067
16. Miwa H, Beran M, Saunders GF (1992) Expression of the Wilms' tumor gene (WT1) in human leukemias. Leukemia 6(5):405-409
17. Inoue K, Ogawa H, Sonoda Y et al (1997) Aberrant overexpression of the Wilms tumor gene (WT1) in human leukemia. Blood 89(4):1405-1412
18. Baird PN, Simmons PJ (1997) Expression of the Wilms' tumor gene (WT1) in normal hemopoiesis. Exp Hematol 25(4):312-320
19. Inoue K, Ogawa H, Yamagami T et al (1996) Long-term follow-up of minimal residual disease in leukemia patients by monitoring WT1 (Wilms tumor gene) expression levels. Blood 88(6):2267-2278
20. Cilloni D, Saglio G (2004) WT1 as a universal marker for minimal residual disease detection and quantification in myeloid leukemias and in myelodysplastic syndrome. Acta Haematol 112(1-2):79-84. doi: 10.1159/ 000077562
21. Tamaki H, Mishima M, Kawakami M et al (2003) Monitoring minimal residual disease in leukemia using real-time quantitative polymerase chain reaction for Wilms tumor gene (WT1). Int J Hematol 78(4):349-356. doi: 10.1007/BF02983561
22. Cilloni D, Gottardi E, De Micheli D et al (2002) Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients. Leukemia 16(10):2115-2121. doi: 10.1038/sj.leu.2402675
23. Inoue K, Sugiyama H, Ogawa H et al (1994) WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. Blood 84(9):3071-3079
24. Omran HA, Shabani M, Vossough P et al (2008) Cross-sectional monitoring of Wilms' tumor gene 1 (WT1) expression in Iranian patients with acute lymphoblastic leukemia at diagnosis, relapse and remission. Leuk Lymphoma 49(2):281-290. doi: 10.1080/10428190701784706
25. Im HJ, Kong G, Lee H (1999) Expression of Wilms tumor gene (WT1) in children with acute leukemia. Pediatr Hematol Oncol 16(2):109-118. doi: 10.1080/088800199277434
26. Boublikova L, Kalinova M, Ryan J et al (2006) Wilms' tumor gene 1 (WT1) expression in childhood acute lymphoblastic leukemia: A wide range of WT1 expression levels, its impact on prognosis and minimal residual disease monitoring. Leukemia 20(2):254-263. doi: 10.1038/sj.leu.2404047
27. Bruggemann M, Raff T, Flohr T et al (2006) Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia. Blood 107(3):1116-1123. doi: 10.1182/blood-2005-07-2708
28. Siehl JM, Thiel E, Heufelder K et al (2003) Possible regulation of Wilms' tumour gene 1 (WT1) expression by the paired box genes PAX2 and PAX8 and by the haematopoietic transcription factor GATA-1 in human acute myeloid leukaemias. Br J Haematol 123(2):235-242. doi: 10.1046/ j.1365-2141.2003.04622.x
29. Siehl JM, Reinwald M, Heufelder K et al (2004) Expression of Wilms' tumor gene 1 at different stages of acute myeloid leukemia and analysis of its major splice variants. Ann Hematol 83(12):745-750. doi: 10.1007/ s00277-004-0941-0
30. Garg M, Moore H, Tobal K et al (2003) Prognostic significance of quantitative analysis of WT1 gene transcripts by competitive reverse transcription polymerase chain reaction in acute leukaemia. Br J Haematol 123(1):49-59. doi: 10.1046/j.1365-2141.2003.04552.x
31. Menssen HD, Siehl JM, Thiel E (2002) Wilms tumor gene (WT1) expression as a panleukemic marker. Int J Hematol 76(2):103-109. doi: 10.1007/ BF02982571
32. Chiusa L, Francia di Celle P, Campisi P et al (2006) Prognostic value of quantitative analysis of WT1 gene transcripts in adult acute lymphoblastic leukemia. Haematologica 91(2):270-271
33. Drakos E, Rassidakis GZ, Tsioli P et al (2005) Differential expression of WT1 gene product in non-Hodgkin lymphomas. Appl Immunohistochem Mol Morphol 13(2):132-137. doi: 10.1097/01.pai.0000143786.62974.66
34. Barragan E, Cervera J, Bolufer P et al (2004) Prognostic implications of Wilms' tumor gene (WT1) expression in patients with de novo acute myeloid leukemia. Haematologica 89(8):926-933
35. Bergmann L, Miething C, Maurer U et al (1997) High levels of Wilms' tumor gene (wt1) mRNA in acute myeloid leukemias are associated with a worse long-term outcome. Blood 90(3):1217-1225
36. Trka J, Kalinova M, Hrusak O et al (2002) Real-time quantitative PCR detection of WT1 gene expression in children with AML: Prognostic significance, correlation with disease status and residual disease detection by flow cytometry. Leukemia 16(7):1381-1389. doi: 10.1038/ sj.leu.2402512